Tsveta Milanova, Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 5,540 shares at $33.54 ($186K) on 2025-06-24, disclosed to the SEC on 2025-06-26.
Scheduled sale ($186k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.54 | 2,770 | $93K | 50.0% |
| 2 | $33.54 | 2,770 | $93K | 50.0% |
| Total | $33.54 avg | 5,540 | $186K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-07 | $78K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-03-04 | $119K | — | Filing → |